MRPL44 haploinsufficient mouse spontaneously develops hypertrophic cardiomyopathy and shows systolic dysfunction after aldosterone treatment

Back

ESC Professional Premium Access

MRPL44 haploinsufficient mouse spontaneously develops hypertrophic cardiomyopathy and shows systolic dysfunction after aldosterone treatment

Session: Novel mechanisms in arrhythmogenic cardiac diseases

Topic: Cardiomyopathies

Speaker: Professor R. Okamoto (Tsu, JP)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Ryuji Okamoto

Mie University Graduate School of Medicine, Tsu (Japan)

0 follower

4 more presentations in this session

Reduced Na current in dystrophin-deficient ventricular cardiomyocytes is rescued by tenascin-C inhibition

Speaker: Ms J. Marksteiner (Vienna, AT)

A novel murine model of stress-induced cardiomyopathy achieved by chemogenetic stimulation of the locus coeruleus-norepinephrine system

Speaker: Doctor S. Ministrini (Zurich, CH)

Phosphoproteomics of PLN R14del heart tissue reveals major myocyte degenerate phenotype, and is attenuated by PLN antisense treatment in vitro

Speaker: Mr F. Deiman (Groningen, NL)

Burst-like transcription of MYH7, allelic and contractile imbalance already in early stage hiPSC-cardiomyocytes indicate these as pathogenic factors in Hypertrophic Cardiomyopathy

Speaker: Doctor T. Kraft (Hannover, DE)

Access the full session

Novel mechanisms in arrhythmogenic cardiac diseases

Speakers: Professor R. Okamoto, Ms J. Marksteiner, Doctor S. Ministrini, Mr F. Deiman, Doctor T. Kraft

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources